Curentis Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.75 M
- Company Age 3 Year, 9 Days
- Last Filing with ROC 31 Mar 2024
About Curentis Biotech
Curentis Biotech Private Limited (CBPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 February 2022 (Three years 9 days old ). Its registered office is in Darjiling, West Bengal, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.75 M, as per Ministry of Corporate Affairs (MCA) records.
Deoranjan Singh, Mrinmoy Paul, Nayan Biswas, and Two other members serve as directors at the Company.
Company Details
- Location
Darjiling, West Bengal, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85190WB2022PTC251681
- Company No.
251681
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Feb 2022
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Curentis Biotech?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nayan Biswas  | Director | 16-Feb-2022 | Current |
| Mrinmoy Paul | Director | 16-Feb-2022 | Current |
| Deoranjan Singh | Director | 16-Feb-2022 | Current |
| Rajasri Debbarma | Additional Director | 14-Jun-2022 | Current |
| Dharma Basnet | Additional Director | 14-Jun-2022 | Current |
Financial Performance of Curentis Biotech.
Curentis Biotech Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Curentis Biotech?
Unlock access to Curentis Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Kashyap Medical & Educational FoundationDeoranjan Singh is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Curentis Biotech?
Curentis Biotech has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Curentis Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Curentis Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.